The pace of change and vast competition in today’s economic climate demand speedy, effective and cutting-edge counsel. Lipa Meir & Co.’s Corporate and M&A department provides insightful counsel to ensure deals are accomplished effectively, efficiently and professionally so that our clients can carry out their chosen transactions on time without disruption to their day-to-day operations.
Our Corporate and M&A department stands out for comprising attorneys with the highest levels of academic training, both domestically and internationally.
Our successful track record in delivering value added transactions at home and abroad continues to attract instructions from an extensive roster of clients operating in the automotive, cyber, energy environment, healthcare, high-tech, insurance, kibbutzim, life sciences, real estate, technology and other sectors.
For example, we regularly provide strategic advice to:
♦ Kibbutzim’s economic organizations, national and regional organizations, the Kibbutz insurance corporation, the Kibbutz purchasing organization, and other kibbutz economic organizations;
♦ Healthcare, pharmaceutical and medical device companies, including Clalit Health Services, Philips, Siemens, GE, Pfizer, Eli Lilly and Co. and others; and
♦ Automotive companies and their subsidiaries, including Raval ACS group, Mag EH Ltd., Tadir-Gan Precision Products 1993 Ltd. M.A.P Motorad Automotive Parts Ltd., and others.
We combine this depth of sector experience with a seamless collaboration with other departments to ensure our clients have immediate access to the most comprehensive advice as they drive their businesses forward.
The Commercial, Corporate and M&A was ranked by The Legal 500: “Led by Uzi Mor, Lipa Meir & Co provides clients with ‘high-level service at an affordable price’. The team is instructed by healthcare groups such as Clalit Health Services and has experience in significant privatisation arrangements. Gary Copelovitz is also recommended.”
News & Publications
14.02.21
From a “Startup Nation” to an “Environment Nation”: “Evolution Water”
Diplomacy
For the first time, an Israeli technological group in the artificial intelligence field has lead and established a pioneering venture for managing the water infrastructure system in the country – In Israel. Dr. Ziv Preis Preis and Tom Nissani of our Cross Border Mergers & Acquisitions, Banking & Finance Department represented Evolution Water, an artificial intelligence company, […]
19.10.20
Mileutis raises $20 million to reduce antibiotic use in cows
calcalistech
Mileutis Ltd., a company based in Ness Ziona, Israel raised $20 million to develop a drug that is designed to treat mastitis in cows. The private venture capital company, U.S.-based NovaQuest Capital Management LLC, which specializes in health and life sciences and oversees some $2 billion in investments, invested in the Israeli company. NovaQuest’s investment […]
19.10.20
Israeli animal health co Mileutis raises $20m
Globes
Mileutis is in advanced stages of development of an innovative product which addresses bovine mastitis, the main concern in the dairy industry. Israeli animal health company Mileutis Ltd. has received a $20 million investment from US life sciences and healthcare investor NovaQuest Capital Management LLC, as part of a product financing agreement. Ness Ziona-based Mileutis […]
16.04.20
The Legal 500 Europe, Middle East & Africa 2020 rankings released
Lipa Meir & Co has been recommended as a TOP-TIER FIRM in 3 practice areas: – Energy – Healthcare and life sciences – Restructuring and insolvency Lipa Meir & Co has also been recommended in the following 13 practice areas: – Banking and finance – Capital markets – Commercial, corporate and M&A – Competition antitrust […]
12.04.20
The Covid-19 black swan muddies the M&A lake
Globes
A common closing condition in M&A agreements is that there has been no material adverse change (MAC clause), or material adverse effect (MAE clause) with respect to the target company and its business, from the date of signing the agreement until the closing of the transaction. In this article, we address whether the COVID 19 epidemic could be […]
06.04.20
A Black Swan in M&A COVID 19 Lake: A Material Adverse Effect that Could Strike at Merger and Acquisition Deals
Newsletter
Many mergers and acquisitions, including investments, have a time period between signing the transaction agreement and closing the transaction. Several factors may lead to that time period such as the need to obtain regulatory approvals (e.g., Competition Authority, the Israeli Lands Authority) to complete the transaction or to obtain the approval of the target company’s […]
25.02.20
You Exercised Your 102 Options to Shares As An Employee – You’re Not Necessarily a Shareholder
Newsletter
An employee exercising options to company’s shares is not necessarily a shareholder with shareholders rights as long as those shares are held by the trustee According to a recent decision in the Haifa District Court – Civil Case 19042-03-18 Navon vs. Sol Chip Ltd. – an employee has been granted options to purchase shares of […]
06.12.18
China’s Newater to Acquire Water Purification Company AMS for $13.5 Million
Calcalist
We are proud to announce the acquisition of the Israeli start-up, AMS Technologies, by Newater, a Chinese public company traded on the NASDAQ. Both companies are engaged in the field of wastewater technologies. AMS was represented by Adv. Gary Copelovitz, Danit Rimon and Gad Keren of our firm. For the full article in Calcalist, click here
